I take issue with AF's style of journalism. He comes out with a negative column based on rumors a week before AASLD, the release of 8-week data in GT2/GT3 patients, and the release of data on the DAA combo with BMY's NS5A. Is Cramer the only guy he works for?
Market Data 
Markets 
AI
